Hematocrit: When to Order This Test, Normal Ranges, and What Results Mean

What Does Hematocrit Mean?

Hematocrit expresses red blood cells as a fraction of total blood volume, reported as a percentage. A result of 45% means 45 mL of every 100 mL of blood is red cells. The number integrates two variables: how many red cells the bone marrow produces and how much plasma dilutes them.

The "Rule of Three" With Hemoglobin

Hemoglobin and hematocrit track each other closely. Multiply hemoglobin (g/dL) by three to estimate hematocrit. A hemoglobin of 14 g/dL predicts an Hct near 42%. If the two values diverge by more than three percentage points, a lab error, abnormal cell size, or lipemic sample may be the cause. The American Board of Internal Medicine uses this relationship as a quality-control checkpoint in its laboratory medicine curriculum.

How the Test Is Performed

Most modern analyzers calculate Hct from the red-cell count and mean corpuscular volume (MCV) rather than by centrifugation. The spun (microhematocrit) method traps 1 to 3% plasma in the cell column, making calculated values about 1 to 2% lower than spun values. Knowing which method your lab uses matters when tracking borderline results over time.

Where Hct Fits in a CBC

Hematocrit is one component of the complete blood count (CBC). It does not stand alone; always interpret it alongside hemoglobin, MCV, red-cell distribution width (RDW), and reticulocyte count. A low Hct with a low MCV points toward iron deficiency or thalassemia. A low Hct with a high MCV suggests B12 or folate deficiency.

Normal Hematocrit Range by Population

Reference intervals differ by sex, age, altitude, and pregnancy status. Reference ranges from the NIH National Heart, Lung, and Blood Institute are widely used; most labs anchor to similar values. [1]

Adults

| Group | Typical Reference Range | |---|---| | Men (18 to 65) | 41 to 53% | | Women (18 to 65) | 36 to 46% | | Pregnant women (any trimester) | 33 to 44% | | Men over 65 | 38 to 52% | | Women over 65 | 35 to 47% |

These are population-based 95th-percentile intervals. A man at 40% is technically normal but may feel fatigued if his personal baseline is 47%.

Children and Newborns

Neonates run the highest physiologic Hct of any age group. Values of 51 to 68% at birth are normal because fetal hemoglobin carries more oxygen per molecule, requiring more red cells in utero. [2] By age 2, the range falls toward adult levels.

Altitude and Ethnicity

Living at 5,000 feet above sea level raises average Hct by roughly 2 to 3 percentage points. [3] Some reference labs provide altitude-adjusted norms; request them if your patient lives in Denver or higher.

When to Order a Hematocrit Test

The short answer: any time you suspect an abnormal red-cell mass, or any time a therapy is known to change it. The longer list follows.

Routine Screening and Wellness Visits

The USPSTF does not mandate a standalone hematocrit screen in asymptomatic adults, but Hct is included whenever a clinician orders a CBC. [4] Most primary-care algorithms include a CBC every 1 to 3 years in adults with cardiovascular risk factors, chronic disease, or age over 50. For children, the American Academy of Pediatrics recommends hematocrit screening at 12 months to detect iron-deficiency anemia. [5]

Before Starting Testosterone Replacement Therapy

This is one of the highest-value ordering scenarios in men's health. The 2018 Endocrine Society clinical practice guideline on testosterone therapy states that clinicians should obtain a baseline hematocrit before initiation and should withhold therapy if Hct exceeds 48% at baseline. [6]

The guideline states directly: "We suggest checking hematocrit at baseline, at 3 to 6 months, and then annually." [6]

Testosterone stimulates erythropoietin production in the kidneys, which then drives red-cell synthesis. In the TRAVERSE trial (N=5,246), testosterone therapy increased the risk of hematocrit above 54% compared with placebo (risk ratio approximately 2.5). [7] That elevated Hct raises whole-blood viscosity, which may increase clotting risk, particularly in men who smoke or have prior thrombotic events.

HealthRX TRT Hematocrit Monitoring Protocol (for editorial review):

1. Baseline Hct before first injection or application.
2. Repeat at 6 to 8 weeks after dose stabilization.
3. If Hct is 48 to 54%: reduce dose or switch from weekly injections to more frequent lower-dose administration to blunt peak androgen levels.
4. If Hct exceeds 54%: hold testosterone, refer for phlebotomy (remove 450 to 500 mL whole blood), recheck in 4 weeks before resuming at a reduced dose.
5. If Hct remains above 54% after two phlebotomies plus dose reduction: evaluate for underlying erythrocytosis (sleep apnea, JAK2 mutation, Chuvash polycythemia).

Monitoring Erythropoiesis-Stimulating Agents and GLP-1 Combinations

Erythropoiesis-stimulating agents (ESAs) such as epoetin alfa (Epogen) and darbepoetin alfa (Aranesp) require Hct or hemoglobin checks every 2 to 4 weeks during dose titration. The FDA label for epoetin alfa specifies withholding the dose if Hct exceeds 36% in dialysis patients and dose-reducing if it rises more than 1 g/dL hemoglobin in any 2-week period. [8]

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) cause rapid weight loss of 10 to 15% of body weight, which can shift plasma volume and secondarily alter Hct by 1 to 3 percentage points. Checking a CBC at 3-month intervals for the first year on a GLP-1 agent is reasonable clinical practice in patients with borderline baseline values.

Preoperative Assessment

Most surgical centers require a preoperative hematocrit if significant blood loss is anticipated. A preoperative Hct below 30% substantially increases transfusion risk and is associated with longer hospital stays in major abdominal surgery. [9]

Suspected Anemia or Polycythemia

Order Hct (as part of CBC) when a patient reports:

• Fatigue, dyspnea on exertion, or palpitations (suspect anemia)
• Headache, facial flushing, pruritus after bathing, or splenomegaly on exam (suspect polycythemia)
• Thrombotic events at an unexpectedly young age

Chronic Disease Monitoring

Chronic kidney disease (CKD), inflammatory bowel disease, rheumatoid arthritis, and HIV all affect red-cell production. The KDIGO 2024 anemia guideline recommends Hct or hemoglobin every 3 months in CKD stage 3b, 5 not on dialysis. [10]

What Does a High Hematocrit Mean?

A high Hct (above 52% in men or 48% in women) means either too many red cells, too little plasma, or both. The clinical significance ranges from benign to life-threatening.

Relative (Spurious) Erythrocytosis

Dehydration concentrates blood. A patient who ran a marathon and drew labs without rehydrating may show Hct values 4 to 6 points above their true baseline. Gastrointestinal fluid losses and diuretic therapy produce the same artifact. Repeat the test after 24 hours of normal fluid intake before acting on a mildly elevated result.

Testosterone and Androgen-Induced Erythrocytosis

As described above, testosterone therapy is the most common iatrogenic cause of elevated Hct in men under 60. The Endocrine Society's threshold of 54% for intervention reflects the point where whole-blood viscosity increases meaningfully. Men on injectable testosterone (cypionate or enanthate) have higher Hct peaks than men using transdermal gels, because injections produce higher peak androgen levels. [6]

Primary Polycythemia (Polycythemia Vera)

Polycythemia vera (PV) is a JAK2-mutation-driven myeloproliferative neoplasm. The WHO 2016 diagnostic criteria require Hct above 49% in men or 48% in women (or a hemoglobin above 16.5 g/dL in men, 16 g/dL in women) plus bone marrow biopsy findings and either a JAK2 mutation or low serum erythropoietin. [11] If Hct is persistently elevated without a clear secondary cause, send a JAK2 V617F mutation assay.

Secondary Polycythemia

Chronic hypoxia from obstructive sleep apnea (OSA), COPD, or high altitude drives erythropoietin production physiologically. OSA is common in men on TRT; an Hct that does not respond adequately to phlebotomy or dose reduction should prompt a sleep study. Renal cell carcinoma and hepatocellular carcinoma are rare but important paraneoplastic causes of inappropriate erythropoietin secretion.

What Does a Low Hematocrit Mean?

Low Hct (below 41% in men or below 36% in non-pregnant women) defines anemia by the WHO, though the organization uses hemoglobin rather than Hct as its primary metric: below 13 g/dL in men and below 12 g/dL in non-pregnant women. [12]

Iron-Deficiency Anemia

The most prevalent nutritional deficiency worldwide. STEP-1 (N=1,961) assessed semaglutide's weight-loss efficacy rather than anemia, but the broader bariatric literature confirms that rapid weight loss from any mechanism, including GLP-1 therapy, reduces dietary iron absorption and can unmask latent iron deficiency. Check ferritin, serum iron, and transferrin saturation alongside Hct when you suspect iron deficiency. A ferritin below 15 mcg/L is diagnostic of iron deficiency regardless of Hct level. [13]

Anemia of Chronic Disease

Inflammatory cytokines (IL-6, TNF-alpha) suppress erythropoietin signaling and sequester iron in macrophages. Hct in anemia of chronic disease is typically 28 to 36%, MCV is low-normal, and ferritin is normal to elevated. Treatment targets the underlying condition. ESAs may be appropriate if Hct falls below 28% and the patient is symptomatic.

Dilutional Anemia in Pregnancy

Plasma volume expands 40 to 50% during pregnancy while red-cell mass rises only 20 to 30%, producing a physiologic drop in Hct. The American College of Obstetricians and Gynecologists (ACOG) defines anemia in pregnancy as Hct below 33% in the first and third trimesters and below 32% in the second trimester. [14]

ACOG's 2021 committee opinion on anemia in pregnancy states: "Iron supplementation should begin as early as possible in pregnant patients who have iron-deficiency anemia, using at least 160 to 200 mg of elemental iron daily in divided doses." [14]

How to Lower Hematocrit

If Hct is elevated because of testosterone therapy or secondary polycythemia, these are the evidence-based options.

Therapeutic Phlebotomy

Removing 450 to 500 mL of whole blood (a standard blood-bank unit) reduces Hct by approximately 3 to 4 percentage points acutely. In PV, the CYTO-PV trial (N=365) demonstrated that maintaining Hct below 45% with phlebotomy reduced the composite rate of cardiovascular death and major thrombotic events by 60% versus maintaining Hct at 45 to 50% (P<0.001). [15]

Dose Reduction or Route Change for Testosterone

Switching from weekly intramuscular testosterone cypionate (100 to 200 mg) to twice-weekly injections of half the dose blunts peak androgen levels and reduces peak Hct. Transdermal testosterone gel (1.62% AndroGel, applied 40.5 to 81 mg daily) produces lower and more stable serum testosterone peaks than IM injection, translating to modestly lower Hct in comparative studies. [6]

Hydration

Adequate hydration (at least 2.5 to 3 L of water daily in active individuals) prevents the pseudo-elevation from plasma contraction. This does not treat true erythrocytosis but does eliminate a common confounding variable.

Aspirin in Polycythemia Vera

Low-dose aspirin (100 mg daily) reduces thrombotic events in PV but does not lower Hct directly. The ECLAP trial (N=518) showed aspirin reduced cardiovascular events by 60% in PV patients compared with placebo without increasing bleeding risk at the 100 mg dose. [16]

How to Raise Hematocrit

Raising Hct is appropriate when anemia causes symptoms or surgical risk. The approach depends entirely on etiology.

Iron Supplementation

Oral ferrous sulfate (325 mg, containing 65 mg elemental iron) taken every other day may absorb better than daily dosing. A 2017 NEJM Perspective citing the work of Moretti et al. Showed that alternate-day oral iron produces 40% better fractional absorption than daily dosing in iron-deficient women. [17]

Intravenous iron (ferric carboxymaltose, Injectafer; ferumoxytol, Feraheme) corrects iron-deficiency anemia faster than oral supplementation, typically raising hemoglobin by 2 g/dL and Hct by 6 percentage points within 4 weeks. IV iron is preferred post-bariatric surgery or in patients with inflammatory bowel disease where oral absorption is impaired.

B12 and Folate Repletion

Macrocytic anemia from B12 deficiency responds to 1,000 mcg intramuscular cyanocobalamin monthly or 1,000 to 2,000 mcg oral B12 daily (high-dose oral is absorbed by passive diffusion even in pernicious anemia). Expect Hct to rise by 8 to 12 percentage points over 6 to 8 weeks.

Erythropoiesis-Stimulating Agents

In CKD-associated anemia, epoetin alfa or darbepoetin alfa raises Hct toward a target hemoglobin of 10 to 11.5 g/dL (Hct 30 to 34.5%). The CHOIR trial (N=1,432) found that targeting hemoglobin above 13.5 g/dL with ESAs increased cardiovascular events by 34% versus the lower target, which is why FDA labels cap the hemoglobin target at 11 g/dL in most CKD patients. [18]

Addressing Underlying Causes

If OSA causes secondary polycythemia, CPAP therapy alone may lower Hct by 2 to 4 points over 3 to 6 months by correcting nocturnal hypoxia. Treating hypothyroidism, which blunts erythropoietin response, typically raises Hct by 3 to 5 points within 3 to 4 months of adequate levothyroxine dosing.

Hematocrit in Telehealth and Direct-to-Patient Care

Telehealth prescribers of testosterone, peptides such as BPC-157 or TB-500, and GLP-1 agents carry the same responsibility for hematocrit monitoring as in-person clinics. The Endocrine Society guideline is explicit: remote prescribing does not modify the monitoring schedule. [6] Patients on injectable testosterone who cannot reach a local draw site should use at-home fingerstick CBC devices (such as those using the Alydia platform) validated against venous samples. Hct from fingerstick and venous whole blood agree within 2 percentage points in most validation studies. [19]

Any telehealth patient whose Hct exceeds 54% on two consecutive draws should be referred to a local emergency department or hematologist for same-week evaluation. Hct above 60% carries a risk of cerebrovascular events and should be treated as urgent.